Your browser doesn't support javascript.
New Onset of Giant Cell Arteritis following ChAdOx1-S (Vaxevria®) Vaccine Administration
Vaccines ; 11(2), 2023.
Article in English | EuropePMC | ID: covidwho-2269506
ABSTRACT
We report a 78-year-old man presenting with persistent headaches in vertex and temporo-parietal area;fatigue, worsening after walking;jaw claudication;scotomas;pharyngodynia;and dry cough after the second dose of the SARS-CoV-2 vaccine (ChAdOx1-S) administration. Laboratory findings showed an elevated C-reactive protein level and FDG-CT PET showed evidence of active large vessel vasculitis with diffuse abnormal artery uptake. Under suspicion of vasculitis, a temporal arteries biopsy was performed;the histopathologic findings demonstrated the transmural inflammatory infiltrate with giant cells, compatible with giant cell arteritis. Although the overall incidence of vaccine-triggered autoimmunity is low, rheumatologists worldwide should be aware of autoimmune diseases as a new potential adverse event of vaccines.
Search on Google
Collection: Databases of international organizations Database: EuropePMC Topics: Vaccines Language: English Journal: Vaccines Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: EuropePMC Topics: Vaccines Language: English Journal: Vaccines Year: 2023 Document Type: Article